Literature DB >> 16221550

Minimal versus conventional cardiopulmonary bypass: assessment of intraoperative myocardial damage in coronary bypass surgery.

Franz F Immer1, Christian Pirovino, Erich Gygax, Lars Englberger, Hendrik Tevaearai, Thierry P Carrel.   

Abstract

OBJECTIVE: Minimal extracorporeal circulation (mini-ECC) is a new technology, consisting of a centrifugal pump, an oxygenator, and a modified suction system. The main advantage of mini-ECC is the reduction of tubing length (reduction of the priming volume). Additional beneficial effects are a decrease of coagulation cascade and a reduction of blood transfusion in patients undergoing coronary artery bypass grafting (CABG) surgery. We compared the intraoperative and early postoperative myocardial damage and outcome of patients who underwent CABG surgery with conventional cardiopulmonary bypass (CPB) or mini-ECC.
METHODS: One hundred and thirty-six consecutive patients who underwent isolated CABG surgery at our institution were prospectively studied. Fifty-four patients (39.7%) were operated with mini-ECC. Patient characteristics were similar in both groups. The most interesting intraoperative details as well as in-hospital outcome were assessed.
RESULTS: There was no difference in mortality between the two groups. Cross-clamping time was similar in both groups (p = 0.07). Defibrillation was required in one patient in the mini-ECC group (1.9%) and in 38 patients (46.3%) in the CPB group (p < 0.001). In the mini-ECC group, the requirement of inotropic support and incidence of atrial fibrillation was significantly lower than in the CPB group. Postoperative creatine kinase isoenzyme MB (CK-MB) and cardiac Troponin I (cTnI) were significantly lower in the mini-ECC group (p < 0.05). Duration of ventilation, length of stay in the intensive care unit and total hospitalization time were significantly shorter in patients operated with mini-ECC (p < 0.05).
CONCLUSION: Mini-ECC is a safe procedure and is followed by a diminished release of CK-MB and cTnI than after CPB. Postoperative recovery is accelerated following mini-ECC and there is a significantly lower incidence of postoperative atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16221550     DOI: 10.1016/j.ejcts.2005.08.019

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  The occurrence of postoperative atrial fibrillation according to different surgical settings in cardiac surgery patients.

Authors:  Marta Jakubová; Peter Mitro; Branislav Stančák; František Sabol; Adrián Kolesár; Paul Cisarik; Vincent Nagy
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-08-26

2.  Initial experiences with a centrifugal-pump based minimal invasive extracorporeal circulation system in pediatric congenital cardiac surgery.

Authors:  Alexander Kadner; Paul Philipp Heinisch; Maris Bartkevics; Serena Wyss; Hans-Joerg Jenni; Gabor Erdoes; Balthasar Eberle; Thierry Carrel
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

3.  Single-center experience with the combination of Cardioplexol™ cardioplegia and MiECC for isolated coronary artery bypass graft procedures.

Authors:  Hendrik Tevaeara Stahel; Silvio Barandun; Emilie Kaufmann; Brigitta Gahl; Lars Englberger; Hansjoerg Jenni; Alberto Weber; Thierry Aymard; Erich Gygax; Thierry Carrel
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

4.  Minimally invasive cardiopulmonary bypass: does it really change the outcome?

Authors:  Marco Ranucci; Giuseppe Isgrò
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

5.  Allogeneic Blood Product Usage in Coronary Artery Bypass Grafting (CABG) with minimalized Extracorporeal Circulation System (MECC) Versus Standard On-Pump Coronary Artery Bypass Grafting.

Authors:  M Lisy; E Schmid; J Kozok; P Rosenberger; U A Stock; G Kalender
Journal:  Open Cardiovasc Med J       Date:  2016-06-30

6.  The effect of using the minimized cardio-pulmonary bypass Systems for Coronary Artery Bypass Grafting in diabetic patients.

Authors:  Turki B Albacker; Mohammed Fouda; Bakir M Bakir; Ahmed Eldemerdash
Journal:  J Cardiothorac Surg       Date:  2021-06-07       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.